[The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats]
- PMID: 17111838
[The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats]
Abstract
Aim: To investigate the possible effect of tetramethylpyrazine (TMP), an active ingredient of a commonly used Chinese herb, on the pharmacokinetics of cyclosporine A (CsA) by intragastric administration in rats.
Methods: Forty male Sprague-Dawley rats were equally divided into four groups by randomized block design according to weight. On the first day, after each fasting rat was intragastrically administered CsA (10 mg x kg(-1)), blood samples (0.2 - 0.25 mL) were collected from the tail vein at 0, 1, 2, 3, 4, 6, 8, 12, 24, 36 and 48 h. From day 4 to day 8, each group began to undergo different pretreatments with intragastric administration of water, verapamil (Ver), low and high dose TMP, separately. On day 9, each group intragastrically co-administered CsA (10 mg x kg(-1)) and different pretreatment compounds mentioned above, then blood samples were collected according to the schedule of the first day. The whole blood concentration of CsA was determined by HPLC. Main pharmacokinetic parameters were calculated and compared by statistic analysis.
Results: In the group of water pretreated and co-administrated with CsA, no significantly different pharmacokinetic parameters of CsA were found. After Ver pretreatment and co-administration with CsA, AUC(0-48 h) and C(max) were increased significantly (P < 0.01 and P < 0.05); T(1/2) beta and CL were markedly prolonged and decreased (P < 0.05); T(max) and V were not apparently influenced. After low dose TMP pretreatment and co-administration with CsA, there was no significant difference in the pharmacokinetic parameters of CsA, in spite of the increasing trends of AUC(0-48 h) and C(max). After high dose TMP pretreatment and co-administration with CsA, AUC(0-48 h) and C(max) of CsA were increased significantly (P < 0.01), but there was no significant change in other parameters.
Conclusion: It was indicated that the high dose of TMP could apparently increase the intragastric absorption extent of CsA, while almost had no effect on its elimination process.
Similar articles
-
Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.Bone Marrow Transplant. 2000 Sep;26(5):545-51. doi: 10.1038/sj.bmt.1702545. Bone Marrow Transplant. 2000. PMID: 11019845
-
Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.Int J Pharm. 2008 Mar 3;351(1-2):8-14. doi: 10.1016/j.ijpharm.2007.09.011. Epub 2007 Sep 15. Int J Pharm. 2008. PMID: 17954018
-
Single-dose and steady state pharmacokinetics of CSA and two main primary metabolites, AM1 and AM4n in patients with rheumatic/autoimmune diseases.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):269-74. doi: 10.5507/bp.2011.020. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 22286813
-
[Clinical use of the interaction between cyclosporine A and its inhibitors].Przegl Lek. 2004;61(12):1444-7. Przegl Lek. 2004. PMID: 15850346 Review. Polish.
-
Factors influencing the pharmacokinetics of cyclosporine in man.Ther Drug Monit. 1991 Nov;13(6):465-77. doi: 10.1097/00007691-199111000-00001. Ther Drug Monit. 1991. PMID: 1771643 Review.
Cited by
-
Simulated Microgravity Alters P-Glycoprotein Efflux Function and Expression via the Wnt/β-Catenin Signaling Pathway in Rat Intestine and Brain.Int J Mol Sci. 2023 Mar 12;24(6):5438. doi: 10.3390/ijms24065438. Int J Mol Sci. 2023. PMID: 36982513 Free PMC article.